Rocuronium Bromide shortage — US supply status & alternatives

Rocuronium Bromide

—

🇦🇺 AUST R 349871 · Medicianz Healthcare Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US🇨🇦 CA🇧🇪 BE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Rocuronium Bromide
Therapeutic category	Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper

Controlled substance	No

Marketing-authorisation holders	Medicianz Healthcare Pty Ltd, Fresenius Kabi Australia Pty Ltd, ACCORD-UK LIMITED, Generics (UK) Limited +9 more

Registrations on file	18

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

13 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Aspen Oss BVWavelength Enterprises LTDFarmhispania SATapi Nl BVGland Pharma LTDGland Chemicals Private LTD+7 more

Manufacturing countries: Netherlands, Israel, Spain, India, China, Italy · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

Rocuronium Bromide

Denver Solutions, LLC DBA Leiters Health · Mar 2025

Class IIdetails ↗

🇺🇸

ROCURONIUM BROMIDE

Mckesson Medical-Surgical Inc. Corporate Office · Feb 2024

Class IIdetails ↗

🇺🇸

Rocuronium Bromide

New England Life Care, Inc. dba Advanced Compounding Solutions · July 2023

Class IIdetails ↗

🇺🇸

Rocuronium Bromide

PharMEDium Services, LLC · Mar 2020

Class IIdetails ↗

🇺🇸

Rocuronium Bromide

PharMEDium Services, LLC · Mar 2020

Class IIdetails ↗

🇺🇸

Rocuronium Bromide

SCA Pharmaceuticals, LLC · Oct 2017

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders18 registrations · 13 MA holders

Product	Strength	Form	Market	MA holder	Status
Medsurge	50 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active
Medicianz	50 mg	—	🇦🇺 AU	Medicianz Healthcare Pty Ltd	Active
ROCURONIUM KABI rocuronium bromide	50 mg	—	🇦🇺 AU	Fresenius Kabi Australia Pty Ltd	Active
ROCURONIUM BROMIDE 10 MG/ML SOLUTION FOR INJECTION/INFUSION IN PRE-FILLED SYRINGE	10 MG	injection	🇬🇧 GB	ACCORD-UK LIMITED	Active
ROCURONIUM BROMIDE 10 MG/ML SOLUTION FOR INJECTION/INFUSION	10 MG	injection	🇬🇧 GB	Generics (UK) Limited	Active
ROCURONIUM BROMIDE 10 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE	10 MG	injection	🇬🇧 GB	LABORATOIRE AGUETTANT	Active
ROCURONIUM BROMIDE 10 MG/ML SOLUTION FOR INJECTION/ INFUSION	10 MG	injection	🇬🇧 GB	IBIGEN SRL	Active
Rocuronium Bromide	10mg/mL	injection	🇺🇸 US	HIKMA PHARMACEUTICALS USA INC.	Active
ESMERON rocuronium bromide	50 mg	—	🇦🇺 AU	Merck Sharp & Dohme Australia Pty Ltd	Active
Dbl Rocuronium Bromide Injection	50mg	—	🇦🇺 AU	Pfizer Australia Pty Ltd	Active
ROCURONIUM BAXTER rocuronium bromide	50mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
ROCURONIUM BAXTER rocuronium bromide	100mg	—	🇦🇺 AU	Baxter Healthcare Pty Ltd	Active
ROCURONIUM MYLAN rocuronium bromide	100mg	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
ROCON rocuronium bromide	50 mg	—	🇦🇺 AU	Medis Pharma Pty Ltd	Active
ROCON rocuronium bromide	100 mg	—	🇦🇺 AU	Medis Pharma Pty Ltd	Active

+3 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.